Laying the Right Foundations for Academic-Biotech Dealmaking

In Vivo

"Sublicensing rights, revenue considerations, licensed know-how and diligence milestones: getting these elements right in deals with academic institutions sets the tone for biotechs as they grow and seek partnering opportunities with big pharma."

Read the article

Related Contacts
Geoffrey Spolyar  Partner Boston